Connect with us

Latuda (lurasidone)

Lurasidone (or LATUDA®) is mainly prescribed to treat schizophrenia and bipolar disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2010

Dosage Forms: 20 mg, 40 mg, 80 mg, 120 mg, 160 mg

Biological Half-life: 18-40 hours

Side Effects: Dizziness, hypotension, blurred vision, weight gain, missed menstruation, decreased libido

Routes of Administration: Oral

Pregnancy Category: B (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.